GMED earnings date and history (2026)
Globus Medical Inc. (GMED) has no scheduled report date on the calendar yet. Its last report, on Thu Nov 5, came in at $1.23 against a $1.20 consensus; the stock moved -12.8% on the news. Not investment advice.
See every company reporting on the earnings calendar or the filed financial statements.
Past reports#
Data provided bySource: Twelve DataNewest first. The surprise is the reported EPS against the consensus going in, in percent; the move is the stock’s close-to-close change over the first session that could trade on the report, shown once that session has settled and only where the report’s timing is established — the earnings calendar, the time the company filed its earnings release with the SEC and the day’s trading volume, by majority.
| Date | Est | Actual | Move |
|---|---|---|---|
| Nov 5, 2026 | $1.20 | $1.23 | -12.8% |
| Aug 6, 2026 | $1.12 | $1.34 | +1.6% |
| May 7, 2026 | $0.92 | $1.12 | -8.4% |
| Feb 24, 2026 | $1.06 | $1.28 | +4.7% |
| Nov 6, 2025 | $0.79 | $1.18 | +35.9% |
| Aug 7, 2025 | $0.76 | $0.86 | +8.5% |
| May 8, 2025 | $0.74 | $0.68 | -23.0% |
| Feb 20, 2025 | $0.76 | $0.84 | -4.6% |
| Nov 5, 2024 | $0.65 | $0.83 | +9.4% |
| Aug 6, 2024 | $0.68 | $0.75 | +2.1% |
| May 7, 2024 | $0.55 | $0.72 | +20.2% |
| Feb 20, 2024 | $0.59 | $0.60 | +1.6% |
| Nov 7, 2023 | $0.54 | $0.57 | -0.7% |
| Aug 3, 2023 | $0.60 | $0.63 | -1.9% |
| May 4, 2023 | $0.51 | $0.53 | +3.3% |
| Feb 21, 2023 | $0.55 | $0.59 | +0.5% |
| Nov 8, 2022 | $0.52 | $0.50 | -4.2% |
| Aug 4, 2022 | $0.54 | $0.56 | +6.9% |
| May 10, 2022 | $0.46 | $0.42 | -1.1% |
| Feb 17, 2022 | $0.48 | $0.49 | -0.1% |
| Nov 4, 2021 | $0.45 | $0.50 | +1.4% |
| Aug 4, 2021 | $0.45 | $0.56 | -0.9% |
About this data#
Report dates, sessions, consensus EPS estimates, reported EPS and surprises are third-party figures, subject to change, and may not be accurate. A quarter whose session is known is shown with it; for one whose session is not, the move is left blank rather than guessed, because a pre-open and an after-close report trade on different sessions. The move is ChartRow's own: the first settled close that could trade on the report over the close before it, price return. Not investment advice.
FAQ#
- Did GMED beat earnings last quarter?
- Yes: on Thu Nov 5 GMED reported $1.23 against a $1.20 consensus, a +2.5% surprise.
- How did GMED stock react to its last earnings?
- GMED moved -12.8% on its last earnings report. It reported on Thu Nov 5, 2026, after the close, so the first trading session that could react was Fri Nov 6. GMED closed at $81.44 on Thu Nov 5 and at $71.05 on Fri Nov 6, and $71.05 ÷ $81.44 − 1 = -12.8%. Both are ChartRow's own settled closing prices.
